Total Payments
$5,028
2024 Payments
$146.11
Companies
16
Transactions
168
Medicare Patients
10,783
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$4,937 (98.2%)
Education$90.92 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,937 | 162 | 98.2% |
| Education | $90.92 | 6 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LEO Pharma Inc. | $1,328 | 78 | $0 (2022) |
| PFIZER INC. | $1,142 | 42 | $0 (2024) |
| GENZYME CORPORATION | $606.15 | 6 | $0 (2022) |
| AbbVie, Inc. | $565.83 | 5 | $0 (2019) |
| Genentech USA, Inc. | $338.51 | 13 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $272.25 | 7 | $0 (2022) |
| Amgen Inc. | $260.09 | 3 | $0 (2022) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $134.42 | 4 | $0 (2021) |
| Celgene Corporation | $120.11 | 2 | $0 (2017) |
| Almirall LLC | $119.35 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.11 | 5 | PFIZER INC. ($79.50) |
| 2023 | $13.43 | 1 | PFIZER INC. ($13.43) |
| 2022 | $751.63 | 13 | Regeneron Healthcare Solutions, Inc. ($249.34) |
| 2021 | $495.29 | 19 | GENZYME CORPORATION ($232.95) |
| 2020 | $447.18 | 19 | PFIZER INC. ($162.01) |
| 2019 | $811.06 | 33 | PFIZER INC. ($304.54) |
| 2018 | $1,522 | 38 | LEO Pharma Inc. ($514.21) |
| 2017 | $840.46 | 40 | LEO Pharma Inc. ($414.32) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.05 | General |
| 05/15/2024 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: DERMATOLOGY | ||||||
| 03/05/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: SURGERY | ||||||
| 01/17/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: Inflammation & Immunology | ||||||
| 01/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: DERMATOLOGY | ||||||
| 02/17/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: DERMATOLOGY | ||||||
| 12/15/2022 | Almirall LLC | KLISYRI (Drug) | Food and Beverage | In-kind items and services | $119.35 | General |
| Category: Dermatology | ||||||
| 11/02/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $101.29 | General |
| Category: DERMATOLOGY | ||||||
| 09/27/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $12.26 | General |
| 06/08/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $107.16 | General |
| Category: Inflammation | ||||||
| 05/26/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $31.56 | General |
| Category: ONCOLOGY | ||||||
| 05/26/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2022 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $124.40 | General |
| Category: Oncology | ||||||
| 04/21/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: ONCOLOGY | ||||||
| 04/13/2022 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: BioOncology | ||||||
| 03/03/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: DERMATOLOGY | ||||||
| 01/18/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: ONCOLOGY | ||||||
| 12/22/2021 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: DERMATOLOGY | ||||||
| 11/10/2021 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $124.64 | General |
| Category: Oncology | ||||||
| 10/28/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: DERMATOLOGY | ||||||
| 10/05/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,376 | 5,950 | $518,265 | $239,818 |
| 2022 | 20 | 2,672 | 6,959 | $596,910 | $275,021 |
| 2021 | 24 | 2,821 | 7,414 | $583,525 | $289,005 |
| 2020 | 24 | 2,914 | 7,457 | $574,715 | $261,534 |
Total Patients
10,783
Total Services
27,780
Medicare Billing
$1.1M
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 569 | 1,274 | $159,250 | $85,266 | 53.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 391 | 597 | $89,550 | $48,269 | 53.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 421 | 780 | $78,000 | $29,209 | 37.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 95 | 154 | $50,050 | $19,605 | 39.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 305 | 2,384 | $47,680 | $12,789 | 26.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 157 | 211 | $15,825 | $8,823 | 55.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $10,500 | $6,335 | 60.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 45 | 55 | $9,075 | $5,760 | 63.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 59 | $8,850 | $5,503 | 62.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 55 | 67 | $8,710 | $4,662 | 53.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 67 | 127 | $22,225 | $3,750 | 16.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 23 | $4,600 | $3,083 | 67.0% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2023 | 40 | 50 | $5,000 | $2,793 | 55.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 31 | 32 | $2,720 | $1,515 | 55.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 12 | 13 | $2,275 | $1,458 | 64.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 19 | $1,330 | $808.26 | 60.8% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 17 | 21 | $2,625 | $190.47 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 613 | 1,425 | $175,150 | $95,256 | 54.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 439 | 704 | $105,600 | $57,380 | 54.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 452 | 850 | $84,070 | $33,069 | 39.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 108 | 181 | $58,825 | $20,953 | 35.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 341 | 2,873 | $57,460 | $15,943 | 27.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 163 | 231 | $17,325 | $10,097 | 58.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 134 | 134 | $16,750 | $8,961 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 66 | $9,900 | $6,203 | 62.7% |
About Dr. Donald Scott, M.D
Dr. Donald Scott, M.D is a Dermatopathology healthcare provider based in Palm Springs, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689631566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Scott, M.D has received a total of $5,028 in payments from pharmaceutical and medical device companies, with $146.11 received in 2024. These payments were reported across 168 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,937).
As a Medicare-enrolled provider, Scott has provided services to 10,783 Medicare beneficiaries, totaling 27,780 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Location Palm Springs, CA
- Active Since 04/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1689631566
Products in Payments
- EUCRISA (Drug) $993.55
- ENSTILAR (Drug) $881.29
- LIBTAYO (Biological) $629.60
- Humira (Biological) $565.83
- Otezla (Drug) $347.72
- Erivedge (Biological) $338.51
- PICATO (Drug) $231.83
- LIBTAYO (Drug) $129.84
- KLISYRI (Drug) $119.35
- DUPIXENT (Drug) $118.96
- XELJANZ (Drug) $116.41
- ADBRY (Biological) $101.29
- SILIQ (Drug) $99.99
- Da Vinci Surgical System (Device) $34.56
- DUOBRII (Drug) $34.43
- CIBINQO (Drug) $32.32
- Hylatopic (Drug) $29.89
- Enbrel (Biological) $28.16
- ODOMZO (Drug) $16.76
- KERYDIN (Drug) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.